Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells-Reference-Cited by-同舟云学术

Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells

Published:2018 Issue:12 Volume:6 Page:3152-3159
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Liu Mei¹²³⁴⁵^ORCID,Yang Tong¹²³⁴⁵,Chen Zhongsi¹²³⁴⁵,Wang Zhifei⁶⁴⁷⁸,He Nongyue¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Bioelectronics

2. National Demonstration Center for Experimental Biomedical Engineering Education (Southeast University)

3. School of Biological Science and Medical Engineering

4. Southeast University

5. Nanjing 210096

6. School of Chemistry and Chemical Engineering

7. Nanjing 211189

8. P. R. China

Abstract

Aptamers are single-stranded DNA or RNA oligonucleotides selected by systematic evolution of ligands by exponential enrichment (SELEX), which show great potential in the diagnosis and personalized therapy of cancers, due to their specific advantages over antibodies.

Funder

National Natural Science Foundation of China

State Key Laboratory of Oral Disease

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM00787J

Reference52 articles.

1. Sequence analysis of mutations and translocations across breast cancer subtypes

2. Breast cancer